SIMCERE PHARMACEUTICAL GROUP Selling and Marketing Expense
SIMCERE PHARMACEUTICAL GROUP reported Selling and Marketing Expense of CNY 1.14 billion for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2013-04-26
CNY
| Period end | Selling and Marketing Expense 12 month |
|---|---|
| 2012-12-31 | 1.14B CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 1.13B CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 1.19B CNY 20-F · filed 2013-04-26 |
| 2009-12-31 | 1.00B CNY 20-F · filed 2012-04-25 |
USD
| Period end | Selling and Marketing Expense 12 month |
|---|---|
| 2012-12-31 | $183.11M 20-F · filed 2013-04-26 |